Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jansen

Showing results (841-850 of 1,087) with videos related to

Pageof 109
Sort By:
Annals of Surgical Oncology|March 7, 2013
Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastasesMaartje A J van den Broek, Celien P H Vreuls, Ali Winstanley, et al.
British Journal of Haematology|April 16, 2008
Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysisIngrid M Overes, Björn de Rijke, Agnes van Horssen-Zoetbrood, et al.
Hemasphere|December 11, 2025
Posttransplantation clonal dynamics of hematopoietic stem cells carrying prenatal and early-life <i>DNMT3A</i> mutationsLucca L M Derks, Konradin F Müskens, Markus J van Roosmalen, et al.
Oncoimmunology|October 6, 2018
<i>Ex vivo</i> AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8<sup>+</sup> T cells for adoptive immunotherapyCharlotte M Mousset, Willemijn Hobo, Yun Ji, et al.
Nature Genetics|July 6, 2010
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromesGorica Nikoloski, Saskia M C Langemeijer, Roland P Kuiper, et al.
British Journal of Haematology|March 25, 2021
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtypeCarolien Duetz, Theresia M Westers, Florentien E M In 't Hout, et al.
Bone Marrow Transplantation|April 7, 2021
Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantationMarjan Cruijsen, Jacobien R Hilberink, Walter J F M van der Velden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2016
CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell ResponsesTim J A Hutten, Soley Thordardottir, Hanny Fredrix, et al.
Cytotherapy|December 21, 2023
Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicityPaulien M M van Hauten, Laura Hooijmaijers, Marcos Vidal-Manrique, et al.
Oncoimmunology|November 23, 2020
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancerRalph Ja Maas, Janneke S Hoogstad-van Evert, Jolien Mr Van der Meer, et al.
Pageof 109

Showing results (841-850 of 1,087) with videos related to

Sort By:
Pageof 109
Annals of Surgical Oncology|March 7, 2013
Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastasesMaartje A J van den Broek, Celien P H Vreuls, Ali Winstanley, et al.
British Journal of Haematology|April 16, 2008
Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysisIngrid M Overes, Björn de Rijke, Agnes van Horssen-Zoetbrood, et al.
Hemasphere|December 11, 2025
Posttransplantation clonal dynamics of hematopoietic stem cells carrying prenatal and early-life <i>DNMT3A</i> mutationsLucca L M Derks, Konradin F Müskens, Markus J van Roosmalen, et al.
Oncoimmunology|October 6, 2018
<i>Ex vivo</i> AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8<sup>+</sup> T cells for adoptive immunotherapyCharlotte M Mousset, Willemijn Hobo, Yun Ji, et al.
Nature Genetics|July 6, 2010
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromesGorica Nikoloski, Saskia M C Langemeijer, Roland P Kuiper, et al.
British Journal of Haematology|March 25, 2021
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtypeCarolien Duetz, Theresia M Westers, Florentien E M In 't Hout, et al.
Bone Marrow Transplantation|April 7, 2021
Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantationMarjan Cruijsen, Jacobien R Hilberink, Walter J F M van der Velden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2016
CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell ResponsesTim J A Hutten, Soley Thordardottir, Hanny Fredrix, et al.
Cytotherapy|December 21, 2023
Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicityPaulien M M van Hauten, Laura Hooijmaijers, Marcos Vidal-Manrique, et al.
Oncoimmunology|November 23, 2020
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancerRalph Ja Maas, Janneke S Hoogstad-van Evert, Jolien Mr Van der Meer, et al.
Pageof 109